pre-IPO PHARMA
COMPANIES
VC
JOBS
NEWS
CONTACT
Close ×
COMPANIES
VC
JOBS
NEWS
CONTACT
amcure PRESS RELEASE ARCHIVE
Oct 22, 2018
amcure Presents First Clinical Data for Lead Compound AMC303 at ESMO 2018 Congress
Aug 6, 2018
amcure Announces First Patient Dosed with AMC303 in Phase Ib Extension Cohort Based on Positive Safety Results
Apr 17, 2018
amcure Presents Pre-Clinical Anti-tumor and Anti-Metastatic Effects of AMC303 at AACR
Jan 15, 2018
amcure Appoints Biotech Executive Heinz Schwer to its Board
Sep 11, 2017
amcure Presents Phase I/Ib Study Design for Lead Compound AMC303 at ESMO 2017 Congress
Aug 31, 2017
amcure Receives Additional €1.75M BMBF Research Grant
Aug 23, 2017
amcure Announces Formation of Inaugural Scientific Advisory Board
Apr 4, 2017
amcure Presents Preclinical Data on Lead Cancer Compound AMC303 at AACR Annual Meeting
Dec 14, 2016
amcure Raises €6 Million in Series B Financing and Expands Advisory Board
Oct 27, 2016
amcure Initiates Clinical Study in Patients to Test Novel Approach for Treating Advanced and Metastatic Cancers
Dec 1, 2015
amcure Awarded BMBF Research Grant Supporting Plans to Advance Lead Candidate into Clinic in 2016
